Himalaya Technologies, Inc. (OTCPK:HMLA) agreed to acquire OTC.WATCH LLC on September 17, 2021. The consideration will be paid via issuance of Series B Preferred shares convertible into 20% of the fully diluted shares of Himalaya Technologies, Inc. or approximately 0.084 million Series B Preferred shares. In a related deal, Himalaya Technologies, Inc. agreed to acquire 19.99% stake in GenBio Inc. on September 17, 2021. Post-completion, OTC.WATCH LLC will be run as a wholly owned subsidiary with a drop-down into Kanab.Club. The transaction is subject to consummation of due diligence.

Himalaya Technologies, Inc. (OTCPK:HMLA) cancelled the acquisition of OTC.WATCH LLC on January 7, 2022. The transaction was canceled after due diligence.